Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study will investigate the effect of a peripheral acting opioid antagonist (PAMORA) on the disease course of patients with recurrent acute inflammation of the pancreas (acute pancreatitis). The study will be conducted by treating outpatients suffering from recurrent acute pancreatitis with a PAMORA (naldemedine) for 12 months.
Epistemonikos ID: bfed982dae870a87d8b0919823217c9596f280db
First added on: May 09, 2024